Therefore, we used an independent RA synovial gene expression cohort (GSE21537) [38] to validate the baseline cIgG-trained signatures for predicting the clinical response to infliximab against TNFα mainly produced by synovial macrophages. Here, TNF is linked to rheumatoid arthritis.